These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 21324392)

  • 1. Simvastatin maintains osteoblastic viability while promoting differentiation by partially regulating the expressions of estrogen receptors α.
    Park JB; Zhang H; Lin CY; Chung CP; Byun Y; Park YS; Yang VC
    J Surg Res; 2012 May; 174(2):278-83. PubMed ID: 21324392
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sweroside promotes osteoblastic differentiation and mineralization via interaction of membrane estrogen receptor-α and GPR30 mediated p38 signalling pathway on MC3T3-E1 cells.
    Wu QC; Tang XY; Dai ZQ; Dai Y; Xiao HH; Yao XS
    Phytomedicine; 2020 Mar; 68():153146. PubMed ID: 32028183
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of 17-α ethynyl estradiol on proliferation, differentiation & mineralization of osteoprecursor cells.
    Park JB
    Indian J Med Res; 2012 Sep; 136(3):466-70. PubMed ID: 23041741
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low dose of doxycyline promotes early differentiation of preosteoblasts by partially regulating the expression of estrogen receptors.
    Park JB
    J Surg Res; 2012 Dec; 178(2):737-42. PubMed ID: 22541278
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Simvastatin promotes osteoblast differentiation and mineralization in MC3T3-E1 cells.
    Maeda T; Matsunuma A; Kawane T; Horiuchi N
    Biochem Biophys Res Commun; 2001 Jan; 280(3):874-7. PubMed ID: 11162604
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of dexamethasone, ascorbic acid, and β-glycerophosphate on osteoblastic differentiation by regulating estrogen receptor and osteopontin expression.
    Park JB
    J Surg Res; 2012 Mar; 173(1):99-104. PubMed ID: 21035140
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effects of fulvestrant, an estrogen receptor antagonist, on the proliferation, differentiation and mineralization of osteoprecursor cells.
    Park JB
    Mol Med Rep; 2013 Feb; 7(2):555-8. PubMed ID: 23179494
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of doxycycline, minocycline, and tetracycline on cell proliferation, differentiation, and protein expression in osteoprecursor cells.
    Park JB
    J Craniofac Surg; 2011 Sep; 22(5):1839-42. PubMed ID: 21959447
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pyk2 deficiency potentiates osteoblast differentiation and mineralizing activity in response to estrogen or raloxifene.
    Posritong S; Hong JM; Eleniste PP; McIntyre PW; Wu JL; Himes ER; Patel V; Kacena MA; Bruzzaniti A
    Mol Cell Endocrinol; 2018 Oct; 474():35-47. PubMed ID: 29428397
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Simvastatin promotes osteoblast viability and differentiation via Ras/Smad/Erk/BMP-2 signaling pathway.
    Chen PY; Sun JS; Tsuang YH; Chen MH; Weng PW; Lin FH
    Nutr Res; 2010 Mar; 30(3):191-9. PubMed ID: 20417880
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Simvastatin induces estrogen receptor-alpha (ER-alpha) in murine bone marrow stromal cells.
    Song C; Wang J; Song Q; Li X; Chen Z; Ma Q; Liu Z; Jia H; Dang G
    J Bone Miner Metab; 2008; 26(3):213-7. PubMed ID: 18470660
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Estrogen enhances differentiation of osteoblasts in mouse bone marrow culture.
    Qu Q; Perälä-Heape M; Kapanen A; Dahllund J; Salo J; Väänänen HK; Härkönen P
    Bone; 1998 Mar; 22(3):201-9. PubMed ID: 9514212
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ugonin K-stimulated osteogenesis involves estrogen receptor-dependent activation of non-classical Src signaling pathway and classical pathway.
    Lee CH; Huang YL; Liao JF; Chiou WF
    Eur J Pharmacol; 2012 Feb; 676(1-3):26-33. PubMed ID: 22192930
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Estrogen receptor mediates simvastatin-stimulated osteogenic effects in bone marrow mesenchymal stem cells.
    Chuang SC; Chen CH; Fu YC; Tai IC; Li CJ; Chang LF; Ho ML; Chang JK
    Biochem Pharmacol; 2015 Dec; 98(3):453-64. PubMed ID: 26410676
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of simvastatin on the osteogenetic behavior of alveolar osteoblasts and periodontal ligament cells.
    Liu S; Bertl K; Sun H; Liu ZH; Andrukhov O; Rausch-Fan X
    Hum Cell; 2012 Jun; 25(2):29-35. PubMed ID: 22399266
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of Titanium Surface Microtopography and Simvastatin on Growth and Osteogenic Differentiation of Human Mesenchymal Stem Cells in Estrogen-Deprived Cell Culture.
    Arpornmaeklong P; Pripatnanont P; Chookiatsiri C; Tangtrakulwanich B
    Int J Oral Maxillofac Implants; 2017; 32(1):e35-e46. PubMed ID: 28095523
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of simvastatin on the differentiation of marrow stromal cells from aging rats.
    Liu M; Wang K; Tang T; Dai K; Zhu Z
    Pharmazie; 2009 Jan; 64(1):43-8. PubMed ID: 19216230
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Simvastatin antagonizes tumor necrosis factor-alpha inhibition of bone morphogenetic proteins-2-induced osteoblast differentiation by regulating Smad signaling and Ras/Rho-mitogen-activated protein kinase pathway.
    Yamashita M; Otsuka F; Mukai T; Otani H; Inagaki K; Miyoshi T; Goto J; Yamamura M; Makino H
    J Endocrinol; 2008 Mar; 196(3):601-13. PubMed ID: 18310456
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Simvastatin induces osteogenic differentiation of MSCs via Wnt/β-catenin pathway to promote fracture healing.
    Zhang M; Bian YQ; Tao HM; Yang XF; Mu WD
    Eur Rev Med Pharmacol Sci; 2018 May; 22(9):2896-2905. PubMed ID: 29771446
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combination of simvastatin and bone morphogenetic protein-2 enhances the differentiation of osteoblasts by regulating the expression of phospho-Smad1/5/8.
    Park JB
    Exp Ther Med; 2012 Aug; 4(2):303-306. PubMed ID: 22970034
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.